Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery
Go back to Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery| Intel (NASDAQ: INTC) | Delayed: 120.09 -3.77 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.86 | 52 Week High | $38.36 | |||
| Open | $123.87 | 52 Week Low | $27.68 | |||
| Day High | $124.25 | P/E | 63.54 | |||
| Day Low | $119.44 | EPS | $1.89 | |||
| Volume | 43,173,790 | |||||
